Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

line portfolio 115 14.18 Astellas Pharma 115 14.18.1 Overview 115 14.18.2 IBS Pipeline Portfolio 115 15 Gastrointestinal Disorder Therapeutics Market: Pipeline Analysis 118 15.1 Preclinical 119 15.2 Phase I 120 15.3 Pipeline II 122 15.4 Phase III 126 15.5 Promising Drugs under Clinical Development for Crohn's Disease 129 15.5.1 Myoconda 129 15.5.2 Traficet-EN (CCX282) 129 15.5.3 MLN0002 (vedolizumab) 129 15.5.4 Orencia (abatacept) 129 15.5.5 ABT-874 129 15.5.6 Stelara 129 15.6 Promising Drugs under Clinical Development for Irritable Bowel Syndrome 130 15.6.1 Linaclotide (Linaclotide Acetate) 130 15.6.2 Asimadoline 130 15.6.3 Xifaxan (Rifaximin) 130 15.6.4 Bifantis (Bifidobacterium infantis 35624) 130 15.6.5 LX-103 131 15.6.6 YM060 (Ramosetron hydrochloride) 131 15.7 Promising Drugs under Clinical Development for GERD 131 15.7.1 XP19986 131 15.7.2 AZD3355 131 15.7.3 ADX10059 132 15.7.4 Vecam 132 15.8 Promising Drugs under Clinical Development for Ulcerative Colitis 132 15.8.1 Prograf (Tacrolimus) 132 15.8.2 Vedolizumab 132 15.8.3 Abatacept 132 15.8.4 Adalimumab 133 15.8.5 Golimumab 133 16 Global Gastrointestinal Disorder Therapeutics Market: Strategic Consolidations 134 16.1 Mergers and Acquisitions 134 16.1.1 Overview 134 16.1.2 GlaxoSmithKline Acquires AZ Tika Of AstraZeneca 134 16.1.3 ViroPharma Acquires Lev Pharmaceuticals 134 16.1.4 UCB Acquires Remaining Stake In Schwarz Pharma 134 16.1.5 Teva Pharmaceutical Acquires Bentley Pharmaceuticals 134 16.1.6 Gilead Sciences Acquires Nycomed Limited 135 16.2 Licensing Agreements 135 16.2.1 Overview 135 17 Global Gastrointestinal Disorder Therapeutics Market : Appendix 138 17.1 Market Definitions 138 17.2 Abbreviations 138 17.3 Research Methodology 139 17.3.1 Coverage 139 17.3.2 Secondary Research 139 17.3.3 Pri
'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Apache Junction, AZ (PRWEB) June 02, 2015 ... of light microscope technology, Yancy Corporation is ... with any desired material and biological sample, displaying the ... and electron bonds between atoms. , Jeff Porter, Co-Founder ... new physics are just that – rare. They come ...
(Date:6/2/2015)... 2015 German-based Moenninghoff has designated the ... for the Moenninghoff product line . ... to announce that the R.M. Hoffman Company will be ... founded in 1916, this is a strategically important step. ... kind of professional distributor we need to successfully grow ...
(Date:6/1/2015)... 2015 Chosen for his engaging ... Uldrich has been selected as keynote speaker for ... He will deliver his keynote: "Don't Stop Thinking ... presentations to the American Medical Association, Blue Cross ... Alcetel-Lucent/Verizon Forum on Wireless Healthcare, United Healthcare, IASIS ...
(Date:6/1/2015)... DUBLIN , June 1, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/jpslnm/oxidative_stress ) has announced the addition of ... Product (Consumables, Instruments, Services), Test Type (Indirect, ... Chromatography, Flow Cytometry), End Users - Global ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
Breaking Biology Technology:Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2
... find a noninvasive method to determine the amount of oxygen ... in a tumor have been linked to a poor outcome. ... surrounding organs and tissues at the same time has been ... Krishna and colleagues, at the National Institutes of Health, Bethesda. ...
... April 22 , HIGHLIGHTS: 2008 Results (all percentage comparisons are to comparable ... Record: Q1 2008 sales reached a new ... four business units also achieving new quarterly sales records ... Organic sales growth of 6.5% was ...
... NEW YORK, April 22 American Oriental,Bioengineering, Inc. (NYSE: ... pharmaceutical and healthcare products in China, today,announced that it ... May 7, 2008 before the market opens., The ... 2008 at 8:00 am ET to,discuss its fiscal first ...
Cached Biology Technology:Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 2Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 3Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 4Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 5Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 6Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 7Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 8Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 9Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 10Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 11Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 12Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 13Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 14Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 15Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 16Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 17Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 18American Oriental Bioengineering to Report First Quarter 2008 Financial Results 2
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
(Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... to separate global warming-linked carbon dioxide from natural gas ... engineers at The University of Texas at Austin who ... sponge that only soaks up certain chemicals, the new ... go through hour-glass shaped pores within it, while impeding ...
... discovered a link between a gene believed to promote ... the body. The finding could help researchers ... with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer,s ... SIRT1, which the researchers found prevents cholesterol buildup by ...
... the light of growing concerns about the separation of ... power of big supermarkets, new research funded by Economic ... the motivations and practices of consumers and producers involved ... as organic vegetable boxes, community gardens and farm animal ...
Cached Biology News:New membrane strips carbon dioxide from natural gas faster and better 2New membrane strips carbon dioxide from natural gas faster and better 3MIT links gene to cholesterol 2Alternative food networks connect ethical producers and consumers and can lead to healthier eating 2
... General description: The Costar strip ejector is ... removal of Costar strips from their holder. ... product number, created to easily match Cornings ... please order under the old Sigma-Aldrich number ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
... of systems provide fast and reliable scalable ... proteomics and drug development laboratories. Staccato systems ... Workstation Series, Application Series and Custom Systems ... a remarkably compact system for performing ELISA ...
Biology Products: